Loading...
XJPX
8129
Market cap1.86bUSD
Dec 05, Last price  
4,562.00JPY
1D
-0.55%
1Q
-18.48%
Jan 2017
95.63%
IPO
1,132.97%
Name

Toho Holdings Co Ltd

Chart & Performance

D1W1MN
XJPX:8129 chart
P/E
14.59
P/S
0.19
EPS
312.73
Div Yield, %
0.59%
Shrs. gr., 5y
-2.16%
Rev. gr., 5y
3.74%
Revenues
1.52t
+2.83%
706,488,000,000773,441,000,000805,414,000,000838,949,000,0001,002,112,000,0001,059,581,000,0001,108,144,000,0001,140,357,000,0001,189,624,000,0001,162,114,000,0001,308,358,000,0001,231,175,000,0001,213,322,000,0001,222,195,000,0001,263,769,000,0001,210,334,000,0001,266,171,000,0001,388,565,000,0001,476,712,000,0001,518,495,000,000
Net income
19.84b
-3.94%
3,612,000,0007,218,000,0008,381,000,000-2,471,000,0008,263,000,0007,283,000,00010,766,000,00011,526,000,00010,407,000,00013,535,000,00021,771,000,00014,225,000,00014,384,000,00013,863,000,00016,230,000,0004,989,000,00013,379,000,00013,630,000,00020,657,000,00019,844,000,000
CFO
-26.68b
L
4,613,000,00024,273,000,000-12,996,000,0009,963,000,0001,998,000,0009,726,000,00019,366,000,00024,558,000,000-18,636,000,00029,347,000,0002,381,000,00016,062,000,00051,978,000,00013,428,000,00010,815,000,0008,768,000,00016,341,000,000-9,000,00059,934,000,000-26,675,000,000
Dividend
Mar 30, 202645 JPY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Toho Holdings Co., Ltd. engages in the wholesale distribution of pharmaceutical products in Japan. It sells prescription pharmaceuticals, reagents, medical devices and materials, OTC drugs, health foods, preventive care, clinical care, community healthcare linkage, and home medical and nursing care, as well as provides support services, including the development and sale of customer support systems, assistance in the start-up of medical institutions and pharmacies, management consulting services, medical support, and personnel recruitment. The company also engages in dispensing pharmacy business; manufacture and sale of generic drugs; and site management organization business that assists various medical institutions with clinical trials under contract, as well as sells software to medical institutions. In addition, it provides various customer support systems, including ENIF, an information terminal for pharmaceutical ordering; ENI-Pharmacy, a support system for the separation of dispensing and prescribing functions; LXMATE HeLios a medical care appointment system; KAITOS, an online medical consultation and medication guidance system; ENIFwin, an inventory control system for large hospitals; ENIFvoice SP/ ENIFvoice SP + A/ ENIFvoice Core, a supporting system for electronic medication history recording with voice recognition; and ENIF Nurse, an operation support terminal for home-visit nurses; and logistics systems. The company was incorporated in 1948 and is headquartered in Tokyo, Japan.
IPO date
Dec 11, 2002
Employees
7,699
Domiciled in
JP
Incorporated in
JP

Valuation

Title
JPY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑032024‑032023‑032022‑032021‑032020‑032019‑032018‑032017‑032016‑03
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT